Tuesday, 03 June 2014
Cineworld: The O2, London, SE10 0DX, UK
Harnessing the immense therapeutic and research potential of stem cells requires extensive quality control to ensure the identity, quality, and safety of the cell. Stem cells of different origin and their capability to differentiate towards a specific phenotype as well as tissue engineered constructs are dependent of all kinds of bioprocesses including cultivation media, biomechanical conditions and purification techniques. All topics dealing with the optimization and analysis of processes leading to defined in vitro cultivated cell lines and engineered tissues – with a special focus on bioreactors – will be discussed in this session. This event has CPD accreditation.
This event is part of
Meeting Chair: Dr Johanna Buschmann, Head of Research Laboratories, University Hospital Zurich, Plastic Surgery, Switzerland
Who Should Attend: All those interested in the use of stem cells for tissue engineered constructs should find this meeting extremely valuable
The deadline for abstract submissions for oral presentation is March 10th 2014
Abstracts for poster presentation only can be submitted up to two weeks before the event. You can download the instructions for authors at